In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Stryker acquires Orthovita for $309mm in cash and debt

Executive Summary

In what is said to be the largest-ever up-front fee for an orthobiologics firm, orthopedic device giant Stryker Corp. is buying Orthovita Inc. for $3.85 per share in cash (a 50% premium) plus $12mm in debt, valuing the deal at about $309mm.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies

UsernamePublicRestriction

Register